Lestaurtinib (CEP-701)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lestaurtinib (CEP-701), covering 2013-12-20 to 2018-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 3]